SOPH

Jurgi Camblong

Known title: Executive ChairmanCIK: 0002007050

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 25, 2026

SOPHiA GENETICS Shares Rise 7% Amid Questions on Momentum. Shares of SOPHiA GENETICS climbed 7% in early trading, pushing the stock toward the upper end of its 52‑week range. The move comes with an RSI of 55.5, indicating moderate momentum, and the stock remains above the $4.85 support level that has been tested 13 times. Analysts keep a target of $9.75, but the recent gain raises questions about how long the upward trend can continue.

this person other insiders at SOPH

Transaction History

SOPH▼ Sell$65K
SOPH▼ Sell$65K
SOPH▼ Sell$145K
SOPH▼ Sell$138K
SOPH▼ Sell$133K
SOPH▲ Buy$14K
SOPH▼ Sell$28K
SOPH▼ Sell$125K
SOPH▼ Sell$48K
SOPH▼ Sell$93K
SOPH▼ Sell$118K
SOPH▼ Sell$118K
SOPH▼ Sell$1K
SOPH▼ Sell$279K
SOPH▲ Buy$144K
SOPH▲ Buy$57K
SOPH▼ Sell$106K
SOPH▼ Sell$2K
SOPH▼ Sell$104K
SOPH▲ Buy$101K
SOPH▼ Sell$186K
SOPH▼ Sell$8K
SOPH▼ Sell$45K
SOPH▼ Sell$21K
SOPH▼ Sell$43K
SOPH▼ Sell$23K
SOPH▼ Sell$87K
SOPH▼ Sell$214K
SOPH▼ Sell$21K
SOPH▼ Sell$18K
SOPH▼ Sell$40K
SOPH▼ Sell$9K
SOPH▼ Sell$14K
SOPH▼ Sell$12K
SOPH▼ Sell$13K
SOPH▲ Buy$0
SOPH▼ Sell$21K

We use analytics to understand how market-wall is used. No personal data is sold.